| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 30,326 | 27,901 | 25,341 | 33,309 | | Cost of Revenue | 9,156 | 22,074 | 19,287 | 30,821 | | | Gross Profit | 21,170 | 5,827 | 6,054 | 2,487 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,485 | 1,025 | 2,706 | (630) | | Non Recurring | (28) | 34 | (6) | 123 | | Others | 1,555 | 1,560 | 1,553 | 1,545 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,122 | 3,208 | 1,802 | 1,449 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 108 | 32 | 80 | 34 | | Earnings Before Interest And Taxes | 4,266 | 3,240 | 1,881 | 1,483 | | Interest Expense | 2,577 | 2,576 | 2,643 | 2,595 | | Income Before Tax | 1,689 | 663 | (761) | (1,112) | | Income Tax Expense | (19) | 7 | 7 | 9 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,841 | 657 | (768) | (1,121) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,708 | 657 | (768) | (1,121) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,708 | $657 | ($768) | ($1,121) |
|
0.11% Nasdaq 0.00%
Income Statement
